Matheson Loren A, Duong Trang T, Rosenberg Alan M, Yeung Rae S M
Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
J Immunol Methods. 2008 Nov 30;339(1):82-9. doi: 10.1016/j.jim.2008.08.003. Epub 2008 Sep 2.
Multicenter studies involving both large and small centers separated by significant distances pose unique challenges to biological sample collection. The objective of this study was to evaluate protocols for determining inflammatory biomarkers that are cost and manpower efficient for handling blood destined for a sample repository. Tempus (Applied Biosystems) and Paxgene (Qiagen) blood collection systems were evaluated for RNA isolation. P100 tubes (BD), containing propriety stabilizers for preservation of plasma proteins, were evaluated for protein content and compared with plasma collected in conventional tubes. Blood for plasma separation was spiked with recombinant TNF-alpha and IL-2 prior to being processed and stored under various conditions. The Tempus RNA system produced a significantly greater yield of RNA at comparable quality when stored at 4 degrees C and shipped at ambient temperature than any other condition tested. The Tempus system was 20% less expensive and required approximately 40% less processing time thereby reducing costs. The P100 system preserved recombinant TNF-alpha in blood shipped at ambient temperature significantly better than conventionally collected plasma that was shipped on dry ice. There was no significant difference in IL-2 levels between the two collection methods and shipping temperatures. The Tempus RNA blood collection tubes and the P100 protein stabilization system provide the opportunity for reliable collection and ambient temperature transport of samples in multicenter studies. This cost-effective, standardized protocol for a large multicenter trial ensures the integrity of biological samples and maximizes study participation by both large and small centers.
涉及距离遥远的大、小中心的多中心研究,在生物样本采集方面面临着独特的挑战。本研究的目的是评估用于确定炎症生物标志物的方案,这些方案在处理送往样本库的血液时具有成本效益且人力高效。对Tempus(应用生物系统公司)和Paxgene(凯杰公司)血液采集系统进行了RNA分离评估。对含有用于保存血浆蛋白的专用稳定剂的P100管(BD公司)进行了蛋白质含量评估,并与在传统管中采集的血浆进行了比较。在处理和在各种条件下储存之前,向用于血浆分离的血液中加入重组肿瘤坏死因子-α和白细胞介素-2。当在4℃储存并在室温下运输时,Tempus RNA系统产生的RNA产量显著更高,且质量相当,优于任何其他测试条件。Tempus系统成本低20%,所需处理时间约少40%,从而降低了成本。P100系统在室温下运输的血液中保存重组肿瘤坏死因子-α的效果明显优于在干冰上运输的传统采集血浆。两种采集方法和运输温度下白细胞介素-2水平无显著差异。Tempus RNA血液采集管和P100蛋白质稳定系统为多中心研究中样本的可靠采集和室温运输提供了机会。这种适用于大型多中心试验的经济高效、标准化方案可确保生物样本的完整性,并使大、小中心的研究参与度最大化。